ERBB2 and cancer: Finally, the HR+ subtype was characterized by “adherence junction organization”, for which the dysregulation is implicated in lobular type breast cancers [51] and “caveolin-mediated endocytosis”, which is prevalent in non-HER2+ cancers [52].